Explore

Recent news and media from the Citizen Stash squad.

Experion Completes First Shipment To The Province Of British Columbia

February 21 2019,: Viridium Pacific Group Ltd. (“Viridium” or the “Company”) (TSXV: VIR) (OTCPink: VIRFF) is pleased to announce its wholly owned subsidiary, Experion Biotechnologies Inc. (“Experion”), a licensed cultivation and processor under the Cannabis Act, has completed its first shipment of Adult-Use cannabis to the province of British Columbia.

Experion’s retail band Citizen Stash has now been shipped to the distribution center and will be available online and at selected retail locations. Citizen Stash’s first retail strain Lemon Zkittle is a hybrid with approximately 60% sativa with mid to high THC levels with a sour citrus aroma and a distinct lemon taste. The strain will offer recreational adult users a product that is relaxing and consistent in its quality and effects. Lemon Zkittle will be available in dried flower, however, Experion is actively working on pre-rolls and oils to complement the offering.

Jay Garnett, President and CEO commented “the launch of our first retail product marks a significant milestone in our business and operations. Lemon Zkittle was selected due to its profile, balance and overall consistent experience for the Adult Use market.”

About Viridium

Viridium Pacific Group Ltd. is the parent company of operating subsidiaries involved in horticultural production (Experion Biotechologies Inc.), medical product production (EFX Labs), property development (Fish Trap Ventures Ltd.), and human resource management (Stave Lake Services Ltd.). Experion Biotechnologies Inc. is a Health Canada licensed producer of cannabis which operates in an 8,300 square-foot indoor facility outside of Mission, BC.

More information about Viridium can be found under the Company’s profile on SEDAR at www.sedar.com.

Disclosure      

This press release contains forward-looking information within the meaning of Canadian securities laws. Although the Company believes that such information is reasonable, it can give no assurance that such expectations will prove to be correct.

Forward looking information is typically identified by words such as: believe, expect, anticipate, intend, estimate, forecast, postulate and similar expressions, or are those, which, by their nature, refer to future events. The Company cautions investors that any forward-looking information provided by the Company are not guarantees of future results or performance, and that actual results may differ materially from those in forward looking information as a result of various factors, including, but not limited to: the state of the financial markets for the Company’s equity securities; recent market volatility; the Company’s ability to raise the necessary capital or to be fully able to implement its business strategies; the risks identified in the Filing Statement, and other risks and factors that the Company is unaware of at this time. The reader is referred to the Filing Statement dated September 25, 2017 and/or the most recent annual and interim Management’s Discussion and Analysis for a more complete discussion of such risk factors and their potential effects, copies of which may be accessed through the Company page on SEDAR at www.sedar.com.

, , , , , , , , , , , , ,

Experion Signs Supply Agreement With British Columbia Liquor Distribution Branch

February 14, 2019: Experion Biotechnologies, a licensed cultivation and processor under the Cannabis Act and a wholly owned subsidiary of Viridium Pacific Group Ltd. (“Viridium” or the “Company”) (TSXV: VIR) (OTCPink: VIRFF) is pleased to announce it signed a supply agreement with the British Columbia Liquor Distribution Branch (“BCLDB”). Experion will supply a variety of Adult-Use cannabis products throughout British Columbia through the BCLDB under the Citizen Stash brand. Experion has received its first PO from the BCLDB and is actively preparing the shipment. We will keep the market informed of product availability and future offerings with other provinces.

Jay Garnett, Viridium’s President and Chief Executive Officer commented: “We are excited to supply our home province with quality Adult-Use flower as we actively expand our distribution across Canada and develop our “added value” product lines to further complement the Adult-Use market.”

Viridium also granted 400,000 options to its director, officers and employees at $0.78 expiring on February 13, 2022 vesting immediately.

About Viridium
Viridium Pacific Group Ltd. is a consumer wellness, medical and biotech innovation company based in British Columbia, and the parent company of operating subsidiaries involved in horticultural production, (Experion Biotechologies Inc.), medical product production (EFX Labs) property development (Fish Trap Ventures Ltd.), and human resource management (Stave Lake Services Ltd.). Experion Biotechnologies Inc., is a Health Canada licensed producer of cannabis, which operates in an 8,300 square-foot indoor facility outside of Mission, BC.
More information about Viridium can be found under the Company’s profile on SEDAR at www.sedar.com.

Disclosure

This press release contains forward-looking information within the meaning of Canadian securities laws. Although the Company believes that such information is reasonable, it can give no assurance that such expectations will prove to be correct. Forward looking information is typically identified by words such as: believe, expect, anticipate, intend, estimate, forecast, postulate and similar expressions, or are those, which, by their nature, refer to future events. The Company cautions investors that any forward-looking information provided by the Company are not guarantees of future results or performance, and that actual results may differ materially from those in forward looking information as a result of various factors, including, but not limited to: the state of the financial markets for the Company’s equity securities; recent market volatility; the Company’s ability to raise the necessary capital or to be fully able to implement its business strategies; the risks identified in the Filing Statement, and other risks and factors that the Company is unaware of at this time. The reader is referred to the Filing Statement dated September 25, 2017 and/or the most recent annual and interim Management’s Discussion and Analysis for a more complete discussion of such risk factors and their potential effects, copies of which may be accessed through the Company page on SEDAR at www.sedar.com.

, , , , , , , , , , , , , , ,

Stand for Something

Subscribe to our newsletter for updates
and curated content delivered to: